Results of the integrated ABC/VEN/frequency analysis of the s01e “antiglaucoma drugs and miotics” group medicines use by indicators of expenses, vital necessity and frequency of use
Keywords:pharmacoeconomic analysis, ABC/VEN/frequency analysis, antiglaucoma drugs, expensiveness, vital necessity, prescription frequency
Pharmacotherapy efficiency for ophthalmology patients with primary open angle glaucoma depends both on pathological process features and physician’s qualification, and on the ability of funds rising to purchase antiglaucoma drugs, as well. One of the pharmaceutical provision optimization mechanisms for the given group of patients is the implementation of the formulary system and mandatory health insurance.
Aim. To substantiate the economic feasibility of including antiglaucoma drugs into the formulary and insurance lists using complex ABC/VEN/frequency analysis.
Materials and methods. The analysis of 758 prescriptions of antiglaucoma drugs for patients having primary open angle glaucoma, which were on the dispensary in hospitals of Vinnitsa region, was carried out.
Results. The ABC-analysis showed that 21% of drugs are the most expendable, while 55% of drugs of the studied group accounted for only 5% of the cost. The VEN-analysis results show that the group of the essential AGD is the most numerous – 82.25%. The complex ABC/VEN analysis allowed determination of the essential and necessary AGD with the highest and mean indexes of POAG pharmacotherapy, which share is 34.48%. During frequency analysis it was determined that 82.76% of POAG treatment schemes contained the essential drugs. Expert estimation data of the expediency of AGD implementation into the formulary and insurance lists, which partially did not corresponded the State formulary content, indicate the necessity to attract more professionals of the certain heath care sector for development of the lists mentioned above.Conclusion. The data, obtained in result of the ABC/VEN/frequency analysis of AGD use, show the necessity of pharmacotherapy optimization for patients having POAG, based on the results of complex pharmacoeconomic studies, under conditions of reforming health care system concerning the insurance medicine implementation in Ukraine
Primary open-angle glaucoma. Adapted clinical guidelines based on evidence (2011). Available at: http://www.dec.gov.ua/mtd/dodatki/816/816dod4_2.doc
Damji, K. F., Freedman, S., Moroi, S. E., Douglas, J. R., Shields, M. B. (2010). Shields’ Textbook of Glaucoma. Lippincott Williams & Wilkins, 656.
Kryvoviaz, O. V. (2013). Farmakoterapiia hlaukomy: suchasnyi stan problemy [Pharmacotherapy of glaucoma: state of the problem]. Farmakolohiia ta likarska toksykolohiia, 4–5 (35), 3–13.
Makarenko, O. V., Kryvoviaz, O. V., Kryvoviaz, S. O. (2014). Porivniannia kursovykh doz protyhlaukomnykh preparativ u DDD /na rik/ na 1 khvoroho ta yikh vartosti dlia vyboru efektyvnoho ta ekonomichno dostupnoho likuvannia [Comparison doses term antiglaucoma drugs in DDD / year / in 1 patient and their value to select effective and affordable treatment]. Klinichna farmatsiia, 18 (3), 25–30.
Kryvoviaz, O. (2016). Antiglaucoma pharmacotherapy: analysis of treatment regimens and efficacy indicators. ScienceRise, 3/4 (20), 46–50. doi: 10.15587/2313-8416.2016.65160
Makarenko, O. V., Kryvoviaz, O. V. (2014). Otsenka kachestva zhizni bolnykh pervichnoy otkrytougolnoy glaukomoy [Quality of life of patients with primary open angle glaucoma]. Materialy nauchnoy konferentsii «Sovremennaya farmatsevtika: teoriya, praktika, eksperimenty», 48–53.
Blihar, V. E. et. al. (2011). Do pitannya vprovadzhennya formulyarnoyi sistemi v Ukrayini [On the issue of implementation of formulary system in Ukraine]. Shidnoevropeyskiy zhurnal gromadskogo zdorov’ya, 1 (13), 70–71.
Stepanenko, A. V., Blikhar, V. Ye. (2014). Intehratsiia formuliarnoi systemy likarskykh zasobiv u systemu standartiv u sferi okhorony zdorovia [Integration of drugs formulary system to the system of standards in health care]. Visnyk problem biolohii i medytsyny, 3 (1), 330–333.
Vorobev, P. A. (2008). Kliniko-ekonomicheskiy analiz v meditsinskoy organizatsii [Clinical and economic analysis in the medical organization]. Ratsionalnaya farmakoterapiya, 1 (10), 5–14.
Pro zatverdzhennja chetvertogo vipusku Derzhavnogo formuljara lіkars'kih zasobіv ta zabezpechennja jogo dostupnostі (2012). Mіnіsterstvo ohoroni zdorov'ja Ukraїni, 209. Available at: http://moz.gov.ua/ua/portal/dn_20120328_209.html
How to Cite
Copyright (c) 2016 Ольга Володимирівна Макаренко, Olena Kryvoviaz
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.